Potential usefulness of protease inhibitor and chloroquine in the treatment of transfusion-associated graft-versus-host disease.
Nishimura
M
M
Akaza
T
T
Tadokoro
K
K
Juji
T
T
D000938:Antigen-Presenting Cells / Q000187:drug effects; D000962:Antimalarials / Q000627:therapeutic use; D001550:Benzamidines; D002738:Chloroquine / Q000627:therapeutic use*; D003603:Cytotoxins / Q000494:pharmacology; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000209:etiology; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D011480:Protease Inhibitors / Q000627:therapeutic use*; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects; D065227:Transfusion Reaction
D000962:Antimalarials; D001550:Benzamidines; D003603:Cytotoxins; D006146:Guanidines; D011480:Protease Inhibitors; D002738:Chloroquine; C032855:nafamostat